Longitudinal MR Spectroscopic Imaging of Pediatric Diffuse Pontine Tumors to Assess Tumor Aggression and Progression
S.B. Thakura,
S. Karimib,
I.J. Dunkelc,
J.A. Koutchera,b,d and
W. Huanga,b
a Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY
b Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY
c Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY
d Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

View larger version (79K):
[in a new window]
|
Fig 1. Postcontrast axial T1-weighted MR image of patient 1 at baseline (A), showing no enhancement, and at follow-up 1 (B), revealing contrast enhancement in the tumor region.
| |

View larger version (46K):
[in a new window]
|
Fig 2. (A) The region of excitation or PRESS box (white) and the phase-encoding matrix (green) for the MR spectroscopic imaging data acquisition are superimposed on an axial FLAIR MR image of patient 1 at baseline. The region of excitation encompasses the lesion (region of hyperintensity on the FLAIR image) and surrounding normal-appearing tissue. (B) Proton spectrum from a voxel in the tumor area (red box) of patient 1 at baseline. (C) Proton spectrum from a voxel in the normal-appearing tissue area (blue box) of patient 1 at baseline. (D) Proton spectrum obtained at follow-up 1 from the same voxel of origin for the spectrum shown in B.
| |

View larger version (82K):
[in a new window]
|
Fig 3. Zoomed 2 x 3 array of proton spectra (A) collected at follow-up 1 from the tumor region of patient 1, where MR imaging contrast enhancement was observed (B).
| |

View larger version (12K):
[in a new window]
|
Fig 4. Scatterplots of Cho/Cr and Cho/NAA (left vertical axis) in the lesion region of interest and NAROI, and CEV (right vertical axis) at baseline, follow-up 1, and follow-up 2 for patients 1 (A) and 2 (B).
| |